Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 6Recruiting 3Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 26Neoplasms 18Prostatic Neoplasms 11Lung Neoplasms 7Sarcoma 6Pancreatic Neoplasms 5Ovarian Neoplasms 5Colorectal Neoplasms 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 3Lymphoma 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Signs and Symptoms 2Papillomavirus Infections 2Pain 2Multiple Myeloma 2Melanoma 2Gastrointestinal Neoplasms 2Financial Stress 2Endometrial Neoplasms 2Depression 2Coitus 2Chronic Pain 2Central Nervous System Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2

Interventions

pembrolizumab 16Radiotherapy 15Drug Therapy 14Paclitaxel 13Cisplatin 12Carboplatin 10Immunotherapy 9Esophagectomy 9Radiation 8Fluorouracil 8Surgical Procedures, Operative 7Capecitabine 7Blood Specimen Collection 7Oxaliplatin 6Nivolumab 6Immune Checkpoint Inhibitors 6Chemoradiotherapy 6nimotuzumab 5Trastuzumab 5130-nm albumin-bound paclitaxel 5sintilimab 4camrelizumab 4Leucovorin 4trastuzumab deruxtecan 3tislelizumab 3patritumab deruxtecan 3Surveys and Questionnaires 3Endoscopy 3Bevacizumab 3toripalimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Esophageal Neoplasms × Surveys and Questionnaires × Clear all
NCT00260559 2026-04-14

Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life

University of Pittsburgh

Recruiting
3,500 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06346080 2026-02-18

MAGECmultiDiCE

KU Leuven

Phase NA Recruiting
2,200 enrolled
Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT03835273 2025-07-03

Oesophagectomy and Chest Wall and Respiratory Function

Imperial College London

Recruiting
100 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡